The Promise of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders - Paperback
$27.99
Quantity
01
Pay over time for orders over $35.00 with
Availability:In StockContributor:Elaine A. Moore, Samantha WilkinsonSeries:McFarland Health TopicsAudience:Young AdultPublish date:2008-12-15Pages:223
Language:EnglishPublisher:McFarland & CompanyISBN-13:9780786437153ISBN-10:786437154UPC:9780786437153Book Category:MedicalBook Subcategory:PharmacologySize:8.80 x 5.90 x 0.70 inchesWeight:0.7518Product ID:SCCJETTXNM
The Promise of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerou...
Series: McFarland Health Topics
Audience: Young Adult
Language:EnglishPublisher:McFarland & CompanyISBN-13:9780786437153ISBN-10:786437154UPC:9780786437153Book Category:MedicalBook Subcategory:PharmacologySize:8.80 x 5.90 x 0.70 inchesWeight:0.7518Product ID:SCCJETTXNM
Elaine A. Moore has worked in hospital laboratories for more than 30 years, primarily in immunohematology and toxicology. She is a freelance medical writer and laboratory consultant. For more information, visit her website at www.elaine-moore.com. She lives in Sedalia, Colorado. Samantha Wilkinson is a patient advocate for multiple sclerosis and LDN. Through her website www.ldners.org she...
Publisher: McFarland & Company
Contributor(s)
Free shipping on orders over $75. Standard shipping takes 3-7 business days. Returns accepted within 30 days of purchase.